98254291 - BIOMATION

Information

• Trademark
• 98254291

• Source

• Serial Number

  98254291

• International Classifications

  • 7 - Machines and machine tools
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 03, 2023
  a year ago

• Transaction Date

  June 04, 2024
  9 months ago

• Status Date

  May 07, 2024
  10 months ago

• Published for Opposition Date

  March 12, 2024
  11 months ago

• Location Date

  May 07, 2024
  10 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  STIGLITZ, SUSAN R

• Attorney Docket Number

  TM022

  Attorney Name

  Mark E. Tetreault

  Law Office Assigned Location Code

  L90

• Owners

  • DEKA Research & Development Corp.

Case File Statements

• GS0401: Manufacturing advisory services; biomanufacturing for others, namely, manufacturing of biologics, cells, scaffolds, matrices, tissues, organs and related biological materials; 3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others; Providing technical information in the field of manufacturing biomaterials, regenerative medicine products, biologics, cells, scaffolds, matrices, tissues, organs and related biological materials, and their manufacturing; processing of medical materials, namely, custom fabrication, and assembly of biologics, cells, scaffolds, matrices, tissues, organs and related biological materials for research, development, and medical purposes; biologic manufacturing for others, namely, isolating and processing biologic tissue products from human tissues for use in regenerative medicine; biologic manufacturing, namely, isolating and processing biologic products from human tissues for use in regenerative medicine
• GS0091: Automated and semi-automated cell culture apparatus for laboratory use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Laboratory equipment and supplies, namely, incubators for cell culturing, cell therapy, tissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Disposable plastic bioreactors for cell culturing; Biochips for the production of three-dimensional living tissues, organs and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposes, namely, a fully integrated system composed primarily of computers, electronic sensors, and monitors, plastic tubing, syringes, and pumps, and metal containers, bottles, and heating plates for use in the creation of biological cell therapies, organs, tissues and autologous cell samples for medical purposes; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research
• GS0071: Biomanufacturing devices for engineering of three-dimensional tissues, organs, and autologous cell samples, namely, 3D bioprinters; Fabrication devices for rejuvenation of tissues, organs, autologous cell samples, namely, tissue rejuvenation devices in the nature of bioprinters
• GS0101: Automated and semi-automated cell culture apparatus for medical use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Medical devices, namely, electromechanical fluidic instruments, and other similar or related devices, which process complex human body fluids for the purpose of separating human cell culture samples, and separating fluids; Medical instruments for processing of human body fluids in the nature of human cell samples, blood, and plasma, and the isolation and concentration of components thereof for the purpose of treating degenerative diseases, and chronic diseases; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatment, blood transfusions, and cell transfusions
• GS0421: Scientific and technological services, namely, scientific research, analysis, design and testing in the field of regenerative medicine, automated production systems for regenerative medicine, biologics, cells, scaffolds, matrices, tissues, organs and related biological materials

Case File Event Statements

• 11/30/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/7/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/27/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/28/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/30/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/30/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/1/2023 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/1/2023 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/1/2023 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/2/2024 - a year ago

  10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/2/2024 - a year ago

  11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/2/2024 - a year ago

  12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/2/2024 - a year ago

  13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/2/2024 - a year ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/16/2024 - a year ago

  15 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 1/29/2024 - a year ago

  16 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 2/1/2024 - a year ago

  17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/1/2024 - a year ago

  18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/1/2024 - a year ago

  19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/1/2024 - a year ago

  20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/1/2024 - a year ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/21/2024 - a year ago

  22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/21/2024 - a year ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/7/2024 - 10 months ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/12/2024 - 11 months ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/12/2024 - 11 months ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/3/2024 - 9 months ago

  27 - TEAS STATEMENT OF USE RECEIVED Type: EISU